a:head use human mini brains for drug discovery.

“CNS drug discovery is amongst the most challenging endeavours in the pharmaceutical industry, however, our disruptive technology using human brain organoids for drug design has the potential to herald a new era in the development of novel medicines for the treatment of brain diseases.” says Oliver Szolar, founding partner and…

Read more

All’s well that ends well

And the winner is … After 4 interesting months batch 3 of the weXelerate Accelerator Program ended today. In these past few months the startups have made quite a journey. On today’s Investor’s Day and Pitch Night 36 startups have impressed the investors and the public alike with their innovative…

Read more